Thanks for the feedback and Duly noted captainblood.
I can relate to LH, as I have been invested for the same amount of time, am a large holder too and probably should have traded along the way, but resisted as I was seduced to believe OBJ's Technology and ACTIVE Partners were far, far, far more serious and advanced, than what they actually were. And unfortunately I, as is the case with all OBJ SH's over the last decade, have been fed a huge amount of BS over the years, of varying degrees, where imo, double standards have existed for Broker's, BoD, SI's & SH's etc, as evidenced by those who were posting on here over 2 years ago, who attended the Sydney Investor Presentation, who had far more product prototype information than the rest of us. I assume they are all pretty unhappy at the moment too. Many years of zero visibility, based on confidentiality clauses, NDA's etc, has conveniently muddied the logical informed decision making of many invested here, me included.
I'm as hard on myself as I am everybody else and as Smac recently highlighted in relation to the BodyGuard Country Approvals process: 'Only management would have those answers and there should be nothing to stop them sharing this information.'. So why are they discussing it with individual Shareholders and not the Market in general? I could excuse the BoD for missing the 'The intention is to launch the first BodyGuard products during calendar 2018.'.........if the BoD had provided some kind of follow thru or explanation as to why it did not occur, but that didn't happen as per usual...never any accountabaility! It makes ZERO business sense to provide BodyGuard Approvals timelines to AGM SH show-ups or SH phone-ins, rather than updating the general market, apart from the usual 'no accountability' card for the OBJ BoD. Lack of accountability was a huge issue for the previous BoD and presumably was to be a lessen learned for the new BoD. I trust they are reading.
New BoD, don't go silent when a deal falls through or when a partner walks away, after promoting said partner. New BoD, don't continue zero follow-thru of ASX released information ie BodyGuard products on shelves by 2018. New BoD, don't provide one-on-one AGM/phone-in information, without informing ALL Shareholders. New BoD, don't try to silence and in the process, insult Shareholders who have supported OBJ for over a decade. New BoD, don't assume all Shareholders have amnesia. New BoD, no more Shareholder Updates that are perceived as a joke. New BoD, I could keep going, but I won't.
And Tomi makes a sound point. One isolated story of a punter now being able to play golf due to the BodyGuard Kneeguard, although I'm happy for him, means diddly squat for a natural product like BodyGuard in an unregulated market, where we were all told it was very quick to market due not NOT being Pharmaceutical, with much lower regulatory barriers. Over six years from conception, to now requiring lawyers to mediate individual country approvals, is another typical OBJ stretch, for products on shelves promised by Calendar 2018, with no accountable explanation to Market. I presume the BoD knew at the time, that the Calendar 2018 'intention' for BodyGuard products on shelves, was fanciful. And I assume SH's will not see anymore of these unsubstantiated predictions from the BoD. What is the point of them anyway, if there has never, ever been any accountability and there never ever will be any accountability or efollow-thru explanations provided.
So yes, I DO have some empathy and compassion for LH's frustration. But thanks for the 'Softie' analogy. It now begs the question, who here is really being soft?
OBJ Price at posting:
1.9¢ Sentiment: Hold Disclosure: Held
(20min delay)